Database Entry Point
max planck institut
mpii logo Minerva of the Max Planck Society

MPI-INF D3 Publications, generated: 2:57, 21 October 2019

Search the publication database

  . Return

Your search returned the following 13 documents:

  1. Alejandro Pironti, Saleta Sierra, Rolf Kaiser, Thomas Lengauer, and Nico Pfeifer
    Simulation of Sanger-sequencing errors in the context of genotypic tropism determination
    In: Antiviral Therapy, Berlin, Germany, 2014, A81 p.
  2. Katarzyna Bozek, Manon Eckhardt, Saleta Sierra, Rolf Kaiser, Hans-Georg Kräusslich, Barbara Müller, and Thomas Lengauer
    An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data
    Retrovirology 9 (1): 60.1-60.15, 2012
  3. Saleta Sierra, Jan Nikolaj Dzbowski, Alejandro Pironti, L Gueney, Alexander Thielen, Stefan Reuter, Stefan Esser, Gerd Fätkenheuer, Thomas Lengauer, Dominik Hider, Daniel Hoffmann, Holger Pfister, Björn Jensen, and Rolf Kaiser
    Optimisation of baseline genotypic testing for safe and efficient maraviroc administration
    In: Journal of the International AIDS Society, Glasgow, UK, 2012, 101-102
  4. Saleta Sierra, Rolf Kaiser, Nadine Lübke, Alexander Thielen, Eugen Schuelter, Eva Heger, Martin Däumer, Stefan Reuter, Stefan Esser, Gerd Fätkenheuer, Herbert Pfister, Mark Oette, and Thomas Lengauer
    Prediction of HIV-1 coreceptor usage (tropism) by sequence analysis using a genotypic approach
    Journal of Visualized Experiments 58: e3264,1-e3264,9, 2011
  5. Hendrik Weisser, André Altmann, Saleta Sierra, Francesca Incardona, Daniel Struck, Anders Sönnerborg, Rolf Kaiser, Maurizio Zazzi, Monika Tschochner, Hauke Walter, and Thomas Lengauer
    Only Slight Impact of Predicted Replicative Capacity for Therapy Response Prediction
    PLoSOne 5 (2): e9044,1-e9044,10, 2010
  6. Nadine Sichtig, Saleta Sierra, Rolf Kaiser, Martin Däumer, Stefan Reuter, Eugen Schülter, André Altmann, Gerd Fätkenheuer, Ulf Dittmer, Herbert Pfister, and Stefan Esser
    Evolution of raltegravir resistance during therapy
    Journal of antimicrobial chemotherapy 64 (1): 25-32, 2009
  7. Kasia Bozek, Alexander Thielen, Saleta Sierra, Rolf Kaiser, and Thomas Lengauer
    V3 loop sequence space analysis suggests different evolutionary patterns of CCR5- and CXCR4-tropic HIV.
    PLoS One 4 (11): e7387:1-e.7387:14, 2009
  8. Saleta Sierra, Rolf Kaiser, Alexander Thielen, Oliver Sander, and Thomas Lengauer
    Genotypic Analysis of HIV Co-Receptor Usage
    In: Entry Inhibitoren - Neue Formen der HIV-Therapie, 2008, 31-39
  9. Michal Rosen-Zvi, Eugen Schülter, Andre Altmann, Saleta Sierra-Aragon, Maurizio Zazzi, Anders Sönnerborg, Mark Oette, Thomas Lengauer, and Rolf Kaiser
    Sustaining lamivudine/emtricitabine, abacavir, zidovudine or atazanavir from a previous treatment shows a clinical benefit
    In: Antiviral Therapy, Sitges, Spain, 2008, A86 p.
  10. Thomas Lengauer, Oliver Sander, Saleta Sierra, Alexander Thielen, and Rolf Kaiser
    Bioinformatics prediction of HIV coreceptor usage
    Nature Biotechnology 25 (12): 1407-1410, 2007
  11. Saleta Sierra, Rolf Kaiser, Alexander Thielen, and Thomas Lengauer
    Genotypic coreceptor analysis.
    European Journal of Medical Research 12 (9): 453-462, 2007

  12. Melanie Balduin, Niko Beerenwinkel, Saleta Sierra, Martin Däumer, Jürgen Rockstroh, Mark Oette, Gerd Fätkenheuer, Bernd Kupfer, Daniel Hoffmann, Joachim Selbig, Herbert Pfister, and Rolf Kaiser
    Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy
    J Clin Virol 34 (4): 277-287, 2005
  13. Kirsten Roomp, Niko Beerenwinkel, Tobias Sing, Eugen Schülter, Joachim Büch, Saleta Sierra-Aragon, Martin Däumer, Daniel Hoffmann, Rolf Kaiser, Thomas Lengauer, and Joachim Selbig
    Arevir: A Secure Platform for Designing Personalized Antiretroviral Therapies Against HIV
    Lecture Notes in Computer Science 4075: 185-194, 2006